JP Morgan Chase’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-63,491
| Closed | -$7K | – | 6222 |
|
|
2018
Q4 | $7K | Sell |
63,491
-1,810,106
| -97% | -$1.19M | ﹤0.01% | 5506 |
|
|
2018
Q3 | $3.19M | Buy |
1,873,597
+93,320
| +5% | +$167K | ﹤0.01% | 3110 |
|
|
2018
Q2 | $3.1M | Sell |
1,780,277
-45,989
| -3% | -$79.5K | ﹤0.01% | 3070 |
|
|
2018
Q1 | $3.34M | Sell |
1,826,266
-937,272
| -34% | -$1.98M | ﹤0.01% | 2906 |
|
|
2017
Q4 | $6.16M | Sell |
2,763,538
-641,839
| -19% | -$1.6M | ﹤0.01% | 2512 |
|
|
2017
Q3 | $8.82M | Buy |
3,405,377
+1,417,177
| +71% | +$4.83M | ﹤0.01% | 2089 |
|
|
2017
Q2 | $8.85M | Buy |
1,988,200
+752,475
| +61% | +$3.1M | ﹤0.01% | 2061 |
|
|
2017
Q1 | $5.76M | Sell |
1,235,725
-42,050
| -3% | -$244K | ﹤0.01% | 2337 |
|
|
2016
Q4 | $7.78M | Sell |
1,277,775
-23,169
| -2% | -$121K | ﹤0.01% | 2104 |
|
|
2016
Q3 | $7.17M | Buy |
1,300,944
+62,748
| +5% | +$294K | ﹤0.01% | 1999 |
|
|
2016
Q2 | $4.71M | Sell |
1,238,196
-65,890
| -5% | -$223K | ﹤0.01% | 2335 |
|
|
2016
Q1 | $3.6M | Buy |
1,304,086
+281,991
| +28% | +$1.02M | ﹤0.01% | 2390 |
|
|
2015
Q4 | $5.79M | Sell |
1,022,095
-133,225
| -12% | -$812K | ﹤0.01% | 2131 |
|
|
2015
Q3 | $6.12M | Buy |
1,155,320
+830,625
| +256% | +$6.43M | ﹤0.01% | 2093 |
|
|
2015
Q2 | $2.69M | Buy |
+324,695
| New | +$1.57M | ﹤0.01% | 2739 |
|
|
2014
Q4 | – | Sell |
-103,399
| Closed | -$287K | – | 4445 |
|
|
2014
Q3 | $287K | Sell |
103,399
-3,779
| -4% | -$13.7K | ﹤0.01% | 3874 |
|
|
2014
Q2 | $436K | Buy |
107,178
+59,152
| +123% | +$251K | ﹤0.01% | 3162 |
|
|
2014
Q1 | $255K | Buy |
+48,026
| New | +$269K | ﹤0.01% | 3342 |
|
|
2013
Q4 | – | Sell |
-21,926
| Closed | -$98K | – | 4340 |
|
|
2013
Q3 | $98K | Sell |
21,926
-16,103
| -42% | -$72.2K | ﹤0.01% | 4183 |
|
|
2013
Q2 | $162K | Buy |
+38,029
| New | +$191K | ﹤0.01% | 4048 |
|
Other funds holding SGYP
JP Morgan Chase's SGYP Position: Q1 2019 in Review
JP Morgan Chase sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 63,491 shares — an estimated $7K sold.
JP Morgan Chase first reported a position in SGYP in Q2 2013 and held it in 20 quarters. The position peaked at $8.85M in Q2 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- JP Morgan Chase reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- JP Morgan Chase sold 63,491 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $7K.
- JP Morgan Chase first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 20 quarters.
- JP Morgan Chase's Synergy Pharmaceuticals, Inc Common Stock position peaked at $8.85M in Q2 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.